Cook Medical is collaborating with physicians around the world to develop the SFA Open-Registry using OpenDoor, the first-ever transparent clinical data management suite.
Using an intuitive on-line web interface called OpenDoor, clinicians can track their patients, view the medical community’s trends in treating peripheral arterial disease and determine the most effective treatment options for their patients. Transparency will be a central objective of the SFA Open-Registry, with results for all treatment types available to participating clinicians. This level of transparency where all treatments types are included, as well as real-time access could lead to a reduction in bias in the presentation of clinical data, and allow participating clinicians access to real world patient results. It will also provide a forum for clinicians to communicate with each other about SFA treatments and outcomes.
The company says this observational registry will enable the exchange of real-world treatment results with other clinicians to find the most effective options for patients, track patient outcomes and view community trends. OpenDoor assists with data visualisation and analysis, while allowing clinicians to compare the outcomes of multiple treatments, identify patient subsets and more. In addition, it could help clinicians analyse with their practice-specific data to monitor patient outcomes.
Structure of the registry
The registry will collect clinical data including procedural and follow-up information (out to 5 years). The data will be accessible within 30 days of entry by the clinicians. It is intended to collect data on SFA cases including those treated with balloon angioplasty, bare metal stents, drug-eluting stents and surgical intervention.
Key features of OpenDoor:
Real-time data analysis
Data visualisation and analytics
Case portfolio management
Online forum for clinician collaboration
Resource library
Concierge service designed to assist clinicians with practice-specific analyses
